Can a new pill slow Parkinson's symptoms?
NCT ID NCT07741045
First seen Aug 03, 2026 · Last updated Aug 13, 2026 · Updated 3 times
Summary
This clinical trial is testing an experimental medication called TJ0113 in people with early-onset Parkinson's disease. The study aims to see if TJ0113 can improve movement symptoms compared to a placebo. About 300 participants will take either TJ0113 or a placebo for 26 weeks, followed by an open-label period where everyone receives TJ0113. The main goal is to measure changes in motor symptoms using a standard Parkinson's rating scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- TJ0113 capsules
- What this could lead to
- If effective, TJ0113 could offer a new treatment option to help control movement symptoms in people with early-onset Parkinson's disease.
- What could go wrong
- This is an early-stage test in a specific group, and results may not apply to all Parkinson's patients. The drug's safety and effectiveness are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY ONSET PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Hospital
Beijing, Beijing Municipality, China
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
-
General Hospital of Nuclear Industry (The Second Affiliated Hospital of Soochow University)
Suzhou, Jiangsu, China
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
-
Henan Provincial People's Hospital
Zhengzhou, Henan, China
-
Huzhou Central Hospital
Huzhou, Zhejiang, China
-
Jiaxing Second Hospital
Jiaxing, Zhejiang, China
-
Lishui Municipal People's Hospital
Lishui, Zhejiang, China
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
-
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
Taizhou Central Hospital
Taizhou, Zhejiang, China
-
Taizhou Hospital of Zhejiang Province
Taizhou, Zhejiang, China
-
The Affiliated Hospital of Hangzhou Normal University
Hangzhou, Zhejiang, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The Third Xiangya Hospital, Central South University
Changsha, Hunan, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
-
Wenzhou Central Hospital
Wenzhou, Zhejiang, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, China
-
Xiangya Hospital, Central South University
Changsha, Hunan, China
-
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dancing away Parkinson's symptoms: tango therapy put to the test
- Gentle bowing, calmer mind: music therapy put to the test for Parkinson's anxiety
- Can a voice therapy program help turkish speakers with Parkinson's speak louder and clearer?
- Can a gene therapy rewire brain cells to ease Parkinson's?
- New sleep drug aims to help Parkinson's patients get a good Night's rest
- Music that moves you: personalized beats may improve walking in Parkinson's